Skip to Content

GSI (Complera emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg)

Generic Name: emtricitabine/rilpivirine/tenofovir

Pill with imprint GSI is Pink, Capsule-shape and has been identified as Complera emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg. It is supplied by Gilead Sciences, Inc..

Complera is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Complera emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GSI

Complera

Generic Name
emtricitabine/rilpivirine/tenofovir
Imprint
GSI
Strength
emtricitabine 200 mg, rilpivirine 25 mg and tenofovir disoproxil fumarate 300 mg
Color
Pink
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antiviral combinations
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Gilead Sciences, Inc.
National Drug Code (NDC)
61958-1101

Get help with Imprint Code FAQs.

Related Images for "GSI"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.